Cytocore Inc Quick Ratio (CYOE) starting from the third quarter 2014 to third quarter 2013, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cytocore Inc  (CYOE)

Cytocore Inc's Quick Ratio

CYOE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2014, Quick Ratio fell to 0.03 above Cytocore Inc average.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Quick Ratio than Cytocore Inc in third quarter 2014. While Quick Ratio total ranking has improved so far during the Q3 2014 to 4556, from total ranking in the second quarter 2014 at 5471.

Explain Quick Ratio?
How much Cash & cash equivalents CYOE´s has?
What are CYOE´s Current Liabilities?




CYOE Quick Ratio (Sep 30 2014)
Q3
(Jun 30 2014)
Q2
(Mar 31 2014)
Q1
(Dec 31 2013)
Q4
(Sep 30 2013)
Q3
Y / Y Current Liabilities Change 79.97 % 78.91 % -38.6 % -43.02 % -45.29 %
Y / Y Cash & cash equivalent Change 1854.55 % - -85.71 % -97.44 % -
Quick Ratio MRQ 0.03 0.05 0 0 0
CYOE's Total Ranking # 4556 # 5471 # 5462 # 4840 # 4966
Seq. Current Liabilities Change 2.92 % 51.65 % 5.66 % 9.13 % 2.31 %
Seq. Cash & cash equivalent Change -31.53 % 31300 % 0 % -90.91 % -



Quick Ratio third quarter 2014 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 25
Healthcare Sector # 674
Overall Market # 4556


Quick Ratio Statistics
High Average Low
0.05 0.01 0
(Jun 30 2014)   (Mar 31 2014)




Financial Statements
Cytocore Inc's Current Liabilities $ 7 Millions Visit CYOE's Balance sheet
Cytocore Inc's Cash & cash equivalent $ 0 Millions Visit CYOE's Balance sheet
Source of CYOE's Sales Visit CYOE's Sales by Geography


Cumulative Cytocore Inc's Quick Ratio

CYOE's Quick Ratio for the trailling 12 Months

CYOE Quick Ratio

(Sep 30 2014)
12 Months
(Jun 30 2014)
12 Months
(Mar 31 2014)
12 Months
(Dec 31 2013)
12 Months
(Sep 30 2013)
12 Months
Y / Y Current Liabilities TTM Growth 0.38 % -24.33 % -43.51 % -32.87 % -18.97 %
Y / Y Cash & cash equivalent TTM Growth 831.58 % 610.87 % -74.51 % -59.57 % 147.83 %
Quick Ratio TTM 0.02 0.02 0 0 0
Total Ranking TTM # 3524 # 3738 # 3211 # 3209 # 3745
Seq. Current Liabilities TTM Growth 16.02 % 18.27 % -14.66 % -14.28 % -12.54 %
Seq. Cash & cash equivalent TTM Growth 62.39 % 2415.38 % -31.58 % -66.67 % 23.91 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2014 to $7.08 millions, cumulative Quick Ratio remained unchanged at 0.02 above the CYOE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 24 other companies have achieved higher Quick Ratio than Cytocore Inc. While Quick Ratio overall ranking has improved so far to 3524, from total ranking during the twelve months ending second quarter 2014 at 3738.

Explain Quick Ratio?
How much Cash & cash equivalents CYOE´s has?
What are CYOE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 25
Healthcare Sector # 396
Within the Market # 3524


trailing twelve months Quick Ratio Statistics
High Average Low
0.02 0.01 0
(Sep 30 2014)   (Mar 31 2014)




Companies with similar Quick Ratio in the quarter ending Sep 30 2014, within Laboratory Analytical Instruments Industry Quick RatioSep 30 2014 MRQ Cash & cash equivalentSep 30 2014 MRQ Current Liabilities
Cytocore Inc  0.03 $ 0.215  Millions$ 7.080  Millions
Pressure Biosciences Inc   0.03 $ 0.098  Millions$ 3.553  Millions
Cybrdi, Inc.  0.01 $ 0.068  Millions$ 5.653  Millions

Date modified: 2026-09-08T15:07:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.